PHARMACEUTICAL TRAINING COMPANY

Seeking capital for acquisition.
This company trains specialized pharmaceutical reps. It continues to post 50% margins regularly. It is a premium brand in a premium market. Revenue and EBITDA is average of last three years. Has run on tough times with the effects of Covid, and founder's serious illness. This presents a tremendous opportunity for quick return to higher revenue with robust sales and marketing restored. Currently under LOI. DD is done. PPM is complete. Closing soon. Looking to fill equity gap. (You may have seen this deal previously posted. This is a refresh with updated info.)

industry
[redacted]
location
[redacted]
revenue
[redacted]
ebitda
[redacted]
proposed price
[redacted]
owner financing
[redacted]
target debt
[redacted]
target equity
[redacted]

It appears you don't have a PDF plugin for this browser.

Click here to download the PDF file.



share: